Dare Bioscience, a San Diego-based biopharmaceutical company focused on women's health, went public on April 10, 2014, and employs 23 staff. Its FDA-approved product, XACIATO, treats bacterial vaginosis, while its clinical and pre-clinical programs address various women's health issues.